Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson's Disease

CONCLUSIONS: The present analyses suggest a need for clinicians to further screen for and treat NMS. Optimizing treatment of NMS according to the national and international treatment guidelines may improve symptomatology and enhance quality of life in late-stage PD.PMID:37854895 | PMC:PMC10581854 | DOI:10.1155/2023/6667339
Source: Parkinsons Disease - Category: Neurology Authors: Source Type: research